MUC4 and familial pancreatic carcinoma: Western blot analysis confirmed that the protein level of phospho STAT1, total STAT1 and MUC4 protein is not altered upon erlotinib treatment in CD18/HPAF pancreatic cancer cells for 24h (Fig. 2D).